In addition, the rate of lumpectomy in patients with TPBC or ER+PR-HER2+ breast cancer was higher (51.2% and 46.9%) than that in patients with ER-PR-HER2+ breast cancer (42.7%). This evidence concerns the gene ESR1 and breast carcinoma.